Cartesian Growth [RENEW] vs Ares Acquisition [AACT] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 15 vital metrics comparison: Cartesian Growth wins in 7 metrics, Ares Acquisition wins in 1 metrics, with 2 ties. Cartesian Growth appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricCartesian GrowthAres AcquisitionBetter
P/E Ratio (TTM)N/A36.50N/A
Price-to-Book RatioN/A0.86N/A
Debt-to-Equity Ratio0.100.01Ares Acquisition
PEG RatioN/A-0.40N/A
EV/EBITDA-944.18-20.13Cartesian Growth
Profit Margin (TTM)0.00%0.00%Tie
Operating Margin (TTM)0.00%0.00%Tie
Return on Equity12.76%4.92%Cartesian Growth
Return on Assets (TTM)-0.50%-1.04%Cartesian Growth
Free Cash Flow (TTM)$-814,232$-929,804Cartesian Growth
1-Year Return5.80%-31.46%Cartesian Growth
Enterprise Value$1.85B$594.62MCartesian Growth
Revenue per Share (TTM)N/A$0N/A
Earnings per Share (Diluted)N/A$0.26N/A
Beta (Stock Volatility)-0.01-0.01Cartesian Growth
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Cartesian Growth vs Ares Acquisition Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Cartesian Growth-1.85%-2.60%-1.62%8.85%23.41%20.34%
Ares Acquisition8.78%8.63%-34.88%-34.25%-33.30%-32.27%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Cartesian Growth5.80%1,583.27%1,912.61%1,912.61%1,912.61%1,912.61%
Ares Acquisition-31.46%-26.51%-26.51%-26.51%-26.51%-26.51%

News Based Sentiment: Cartesian Growth vs Ares Acquisition

Cartesian Growth

News sentiment data is not available for Cartesian Growth at this time.

Ares Acquisition

News based Sentiment: MIXED

The month saw significant funding secured for the Ares/Kodiak merger, alongside substantial institutional investment. However, the stock experienced volatility and analysts maintain a 'Hold' rating, creating a mixed investment narrative. The upcoming shareholder meeting is a key catalyst.

View Ares Acquisition News Sentiment Analysis

Performance & Financial Health Analysis: Cartesian Growth vs Ares Acquisition

MetricRENEWAACT
Market Information
Market Cap i$1.84B$421.26M
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1,113870,233
90 Day Avg. Volume i371607,118
Last Close$138.87$7.43
52 Week Range$110.08 - $147.87$5.77 - $11.62
% from 52W High-6.09%-36.06%
All-Time High$147.87 (Jul 23, 2025)$11.62 (Jun 02, 2025)
% from All-Time High-6.09%-36.06%
Growth Metrics
Quarterly Revenue GrowthN/AN/A
Quarterly Earnings Growth-0.70%-0.95%
Financial Health
Profit Margin (TTM) i0.00%0.00%
Operating Margin (TTM) i0.00%0.00%
Return on Equity (TTM) i0.13%0.05%
Debt to Equity (MRQ) i0.100.01
Cash & Liquidity
Book Value per Share (MRQ)$-1.56$-0.39
Cash per Share (MRQ)$0.02$0.00
Operating Cash Flow (TTM) i$-814,232$-2,491,593
Levered Free Cash Flow (TTM) i$-425,497$942,876
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00N/A

Valuation & Enterprise Metrics Analysis: Cartesian Growth vs Ares Acquisition

MetricRENEWAACT
Price Ratios
P/E Ratio (TTM) iN/A36.50
Forward P/E iN/AN/A
PEG Ratio iN/A-0.40
Price to Sales (TTM) iN/AN/A
Price to Book (MRQ) iN/A0.86
Market Capitalization
Market Capitalization i$1.84B$421.26M
Enterprise Value i$1.85B$594.62M
Enterprise Value Metrics
Enterprise to Revenue iN/AN/A
Enterprise to EBITDA i-944.18-20.13
Risk & Other Metrics
Beta i-0.01-0.01
Book Value per Share (MRQ) i$-1.56$-0.39

Financial Statements Comparison: Cartesian Growth vs Ares Acquisition

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)RENEWAACT
Revenue/Sales i$0$0
Cost of Goods Sold iN/AN/A
Gross Profit iN/AN/A
Research & Development iN/AN/A
Operating Income (EBIT) i$-195,387$-2.71M
EBITDA i$-273,251$-8.40M
Pre-Tax Income i$559,864$2.99M
Income Tax iN/AN/A
Net Income (Profit) i$559,864$2.99M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)RENEWAACT
Cash & Equivalents i$81,252$657,314
Total Current Assets i$285,087$747,611
Total Current Liabilities i$3.97M$3.09M
Long-Term Debt i$4.48M$5.00M
Total Shareholders Equity i$64.86M$531.65M
Retained Earnings i$-20.82M$-24.75M
Property, Plant & Equipment iN/AN/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)RENEWAACT
Operating Cash Flow i$-117,523$2.99M
Capital Expenditures iN/AN/A
Free Cash Flow i$-155,448$-318,005
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricRENEWAACT
Shares Short iN/A26,618
Short Ratio iN/A0.10
Short % of Float iN/A0.00%
Average Daily Volume (10 Day) i1,113870,233
Average Daily Volume (90 Day) i371607,118
Shares Outstanding i13.00M62.50M
Float Shares i5.31M39.98M
% Held by Insiders iN/AN/A
% Held by Institutions iN/AN/A

Dividend Analysis & Yield Comparison: Cartesian Growth vs Ares Acquisition

MetricRENEWAACT
Last 12-Month Dividend i$0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$0.01N/A
3-Year Avg Dividend Yield i0.22%N/A
3-Year Total Dividends i$0.02N/A
Ex-Dividend DateDec 01, 2022N/A